Zoetis Holds Annual Meeting of Shareholders
May 15 2018 - 12:00PM
Business Wire
Speaking to shareholders at the Zoetis Inc. (NYSE:ZTS) annual
meeting today in Short Hills, N.J., Chief Executive Officer Juan
Ramón Alaix discussed the company’s strong performance over the
past five years and strategies for continued growth as the leader
in the global animal health industry.
“In 2017, we delivered our fifth consecutive year of operational
revenue growth and increased profitability based on deep
relationships with customers, innovative research and development,
and high-quality manufacturing and supply,” said Alaix. “As we look
to the future, we are energized by the growth opportunities in
animal health that will keep us on the path of continued industry
leadership, and we remain firmly committed to delivering on the
long-term value proposition that has generated returns for our
investors.”
Zoetis Chairman Michael McCallister presided over the business
portion of the meeting and shareholder voting. Preliminary results
of shareholder voting from the meeting are as follows:
- Sanjay Khosla, Willie M. Reed, Linda
Rhodes and William C. Steere, Jr. have been elected as directors
for three-year terms.
- Shareholders approved, on an advisory
basis, the compensation of the company’s named executive
officers.
- Shareholders ratified and approved the
selection of KPMG LLP as the company’s independent registered
public accounting firm for fiscal year 2018.
The final results of the shareholder voting are subject to
verification by the independent election inspector; results will be
filed in a Form 8-K and available on the Investor section of the
Zoetis website.
A full replay of the meeting will be made available at
http://investor.zoetis.com/events-presentations, along with the
presentation materials from the event.
About Zoetis
Zoetis is the leading animal health company, dedicated to
supporting its customers and their businesses. Building on more
than 60 years of experience in animal health, Zoetis discovers,
develops, manufactures and markets veterinary vaccines and
medicines, complemented by diagnostic products, genetic tests,
biodevices and a range of services. Zoetis serves veterinarians,
livestock producers and people who raise and care for farm and
companion animals with sales of its products in more than 100
countries. In 2017, the company generated annual revenue of $5.3
billion with approximately 9,000 employees. For more information,
visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-Looking
Statements: This press release contains forward-looking
statements, which reflect the current views of Zoetis with respect
to business plans or prospects, future operating or financial
performance, future guidance, and other future events. These
statements are not guarantees of future performance or actions.
Forward-looking statements are subject to risks and uncertainties.
If one or more of these risks or uncertainties materialize, or if
management's underlying assumptions prove to be incorrect, actual
results may differ materially from those contemplated by a
forward-looking statement. Forward-looking statements speak only as
of the date on which they are made. Zoetis expressly disclaims any
obligation to update or revise any forward-looking statement,
whether as a result of new information, future events or
otherwise. A further list and description of risks,
uncertainties and other matters can be found in our Annual Report
on Form 10-K for the fiscal year ended December 31, 2017, including
in the sections thereof captioned “Forward-Looking Statements and
Factors That May Affect Future Results” and “Item 1A. Risk
Factors,” in our Quarterly Reports on Form 10-Q and in our Current
Reports on Form 8-K. These filings and subsequent filings are
available online at www.sec.gov, www.zoetis.com, or on
request from Zoetis.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180515006286/en/
ZoetisMedia:Kristen Seely1-973-443-2777
(o)kristen.seely@zoetis.comorInvestor:Steve
Frank1-973-822-7141 (o)steve.frank@zoetis.com
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jul 2023 to Jul 2024